Up | AC
Home Page
Food and
Drug Administration
Anti-Infective Drugs
Advisory Committee
November 18, 2008
BRIEFING INFORMATION
FDA
Disclaimer
Portions of this document have been determined to be exempt
from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. §
552).
FDA Briefing Material (pdf)
Targanta Therapeutics Corporation (Added 11/14/08)
Disclaimer
The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.
Briefing Material (pdf)